Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02195895 · ClinicalTrials.gov registry record · Phase 2
Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT02195895 is a Phase 2 study that has completed, run by Northwestern University. The registered enrollment target is 17 participants.
The verdict
NCT02195895, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a year of alendronate treatment will maintain or increase bone mass density (BMD) compared to baseline BMD values in people with chronic spinal cord injury (SCI). This study will also investigate 1) if alendronate therapy will increase bone strength in people with chronic SCI, 2) the number of participants with adverse events from alendronate, and 3) the effects of alendronate on serum markers of bone metabolism.
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- DRUG Alendronate
- DIETARY_SUPPLEMENT Calcium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-08-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02195895
The ClinicalTrials.gov registry entry for NCT02195895 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vitamin D is the first listed.
NCT02195895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02195895 about?
NCT02195895 is a clinical study titled "Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide". The purpose of this study is to determine if a year of alendronate treatment will maintain or increase bone mass density (BMD) compared to baseline BMD values in people with chronic spinal cord injury (SCI). This study will also investigate 1) if alendronate therapy will increase bone strength in p...
What is the current status of trial NCT02195895?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2014-04. Estimated completion is 2016-08-05.
What interventions are being tested in trial NCT02195895?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), Alendronate (DRUG), Calcium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02195895?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.